These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1184096)

  • 1. [Seroimmunity against rubella 5 years after immunisation with Cendehill vaccine (author's transl)].
    Sarateanu DE; Ehrengut W
    Immun Infekt; 1975 Apr; 3(2):51-3. PubMed ID: 1184096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
    Ehrengut W; Florent G
    Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective and controlled mass rubella vaccination - experiences with an economical method (author's transl)].
    Zippel C; Federmann G; Leidel J; Eggers HJ
    Immun Infekt; 1982 Mar; 10(2):69-75. PubMed ID: 7040210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological assay of measles and rubella immunity in a sample of infantile population in palermo (author's transl)].
    Arista S; Ammatuna P; Leggio M; Chiarini A
    Ann Sclavo; 1980; 22(1):42-8. PubMed ID: 7247483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
    Müller G; Baumann H
    Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to experimental challenge in persons immunized with different rubella vaccines.
    Fogel A; Gerichter CB; Barnea B; Handsher R; Heeger E
    J Pediatr; 1978 Jan; 92(1):26-9. PubMed ID: 619075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella antibody persistence after immunization.
    Herrmann KL; Halstead SB; Wiebenga NH
    JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rubella vaccination with "Cendehill" and "RA 27/3". Reinfection of vaccinated and naturally immune persons compared with the infection rate of susceptible persons within a 3-resp. 5-year observation period (author's transl)].
    Thomssen R
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):163-84. PubMed ID: 1015009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.